Bayesian Capital Management’s Athenex, Inc. Common Stock ATNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-610
Closed -$3K 1105
2022
Q3
$3K Buy
+610
New +$6.27K ﹤0.01% 660

Other funds holding ATNX

Bayesian Capital Management's ATNX Position: Q4 2022 in Review

Bayesian Capital Management sold out of Athenex, Inc. Common Stock (ATNX) in Q4 2022, closing a stake of 610 shares — an estimated $3K sold.

Bayesian Capital Management first reported a position in ATNX in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 53 funds tracked by Wall St. Rank hold ATNX as of Q4 2022.

  • Bayesian Capital Management reported no remaining Athenex, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 610 Athenex, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Bayesian Capital Management first reported a position in Athenex, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Bayesian Capital Management's Athenex, Inc. Common Stock position peaked at $3K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Athenex, Inc. Common Stock as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.